Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Babies in a rural area of India are less likely to suffer from acute malnutrition where their families are taking part in a job-guarantee programme to provide work with a guaranteed wage, an Oxford University study has found. The Indian government programme appears to have no effect on long-term malnutrition.

While wages earned through the scheme helped families avoid starvation when seasonal agricultural jobs were in short supply, many mothers complained wages were paid late or not in full. This means that the intended benefits of the programme were not delivered in full, the researchers say.

The Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) is a job-guarantee scheme in rural India which provides adults willing to do unskilled manual work with at least 100 days of work in every financial year, paid at the statutory minimum wage. MGNREGA is intended to target deprivation and food insecurity in rural households, and because of this, it has been suggested the policy may indirectly improve the health of babies and young children in these households.

Since child malnutrition is a major public health problem in India, researchers at the University of Oxford set out to investigate whether MGNREGA could improve the nutritional status of children below the age of 12 months. This is thought to be the first study to analyse the effect of the MGNREGA programme on infant nutrition. The team measured the weight and length of infants in 528 households spread across the Dungarpur district of Rajasthan, where MGNREGA has been implemented since September 2006. 53% of these households had received employment through MGNREGA during the study period. The researchers also interviewed the mothers of these children and conducted 11 focus group discussions with 62 of the mothers. 

Dr Manisha Nair of the Nuffield Department of Population Health at Oxford University led and carried out the study as part of her DPhil research as a Weidenfeld scholar. She says: ‘We found that children in households employed through the MGNREGA programme were less likely to suffer from recent malnutrition compared with children in households that did not participate in the scheme. However, we did not find any effect of the programme on long term malnutrition.’

The researchers used statistical modelling to understand the likely cause of this beneficial effect on infant nutrition. They found that the effect was not because of improvements in household food security or infant feeding, which they would have expected. Instead, it came through improved birth weights of the infants.

‘It is possible that the programme contributes to better nutrition in pregnant women which leads to improved birth weight,’ suggests Dr Nair, who is originally from Assam and did her medical training at Assam Medical College in Dibrugarh. ‘However further investigation is needed to examine this.’

As well as complaints about problems with receiving wages earned through MGNREGA, the focus group discussions showed that a number of mothers didn’t have a full understanding of appropriate feeding and weaning of infants. The researchers say this could act as a barrier to translating the full economic benefits of the guaranteed wage.

‘It is important to identify and address these factors and target the persistent problem of child malnutrition prevalent in India through a convergence of development, health and nutrition policies and programmes,’ says Dr Nair.

The positive effect of the MGNREGA programme on childhood nutrition was observed only in the poorest households, the researchers report. At present, households can participate in MGNREGA regardless of their socioeconomic status, though the programme’s design tends to ensure that only those that need it apply. However, among the households included in this study, 44% of the poorer households did not receive employment through MGNREGA while around 50% of the relatively better off households did. The team suggests that better targeting of the scheme towards the more disadvantaged households could increase the effectiveness of MGNREGA, making better use of limited resources.

‘This study shows that the MGNREGA programme has the potential to reduce recent malnutrition in children. However, the economic benefits of the job guarantee scheme appear to be short term, and insufficient to have an effect on long term malnutrition,’ concludes Dr Nair. ‘Ensuring timely and adequate payment could improve food security and increase the protective effect of the programme.’

She says similar studies are required to measure the effect of MGNREGA on child nutrition in different social, economic and geographical settings in India.

The researchers report their findings in the journal PLOS ONE

Source: Oxford University press release

Link: 
Nuffield Department of Population Health

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.

Oxford-led technology to help those at high risk from Covid-19

Coronavirus COVID-19 General Research

More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus.